Disease course and outcome of progressive interstitial lung disease in systemic sclerosis
A. Hoffmann-Vold (Oslo, Norway), Y. Allanore (Paris, France), M. Alves (Ingelheim am Rhein, Germany), N. Graf (Winterthur , Switzerland), P. Airò (Brescia, Italy), L. Ananyeva (Moscow, Russian Federation), L. Czirják (Pécs, Hungary), S. Guiducci (Florence, Italy), E. Hachulla (Lille, France), M. Li (Beijing, China), C. Mihai (Zurich, Switzerland), G. Riemekasten (Lübeck, Germany), P. Sfikakis (Athens, Greece), G. Valentini (Napoli, Italy), O. Kowal-Bielecka (Bialystok, Poland), O. Distler (Zurich, Switzerland)
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hoffmann-Vold (Oslo, Norway), Y. Allanore (Paris, France), M. Alves (Ingelheim am Rhein, Germany), N. Graf (Winterthur , Switzerland), P. Airò (Brescia, Italy), L. Ananyeva (Moscow, Russian Federation), L. Czirják (Pécs, Hungary), S. Guiducci (Florence, Italy), E. Hachulla (Lille, France), M. Li (Beijing, China), C. Mihai (Zurich, Switzerland), G. Riemekasten (Lübeck, Germany), P. Sfikakis (Athens, Greece), G. Valentini (Napoli, Italy), O. Kowal-Bielecka (Bialystok, Poland), O. Distler (Zurich, Switzerland). Disease course and outcome of progressive interstitial lung disease in systemic sclerosis. 3598
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: